KPS strengthens growth initiatives amid challenging market conditions
KUALA LUMPUR: Kumpulan Perangsang Selangor Bhd (KPS) plans to step up its sales development efforts, aiming to expand its customer base further and diversify revenue streams across key markets.
'Capital expenditure will be allocated to enhance manufacturing capacity and capabilities to ensure operational readiness to meet evolving customer demands and scale future growth,' it said in a statement.
Managing director and group chief executive officer Ahmad Fariz Hassan said the initiatives collectively reflected KPS' commitment to sustainable value creation, operational discipline, and strategic agility in navigating both opportunities and challenges in the quarters ahead.
'To this effect, we are also actively reviewing our product mix to prioritise higher-margin offerings and exploring price adjustments where practicable. These actions will also be essential to capturing growth opportunities,' he added.
In the first quarter ended March 31, KPS posted a lower net profit of RM7.5mil, or earnings per share of 1.40 sen compared with RM48.5mil, or 9.00 in the year-ago quarter.
Revenue for the quarter dipped to RM243.5mil against RM262.1mil achieved last year.
KPS said the operating environment during the quarter remained challenging, marked by a sluggish demand recovery and persistently high input costs. Global economic activity continued to lose momentum, weighed down by shifting U.S. trade policies and subdued consumer sentiment.
'For the group, however, it was selectively opportunistic: Strong orders from new projects in consumer electronics and medical divisions had furthered growth at Toyoplas Manufacturing (M) Sdn Bhd and MDS Advance Sdn Bhd, respectively. On the contrary, Century Bond Bhd (CCB) faced lower offtake, demand volatility, and further price competition,' it said.
'While we acknowledge that the performance across our subsidiaries has been mixed in the past quarters, with some areas facing headwinds, we are proactively implementing measures to address these challenges.
'Operationally, we have undertaken further consolidation exercises and business rationalisation activities to streamline production planning, as with the case of CBB. These structural changes are aimed at restoring competitiveness and shaping long-term profitability.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
2 days ago
- The Sun
F88 earns Gold Level Certification for Client Protection
HANOI, VIETNAM - Media OutReach Newswire - 18 July 2025 - F88, a pioneer in Việt Nam's alternative finance sector, has once again affirmed its leadership position by being awarded the Gold Level Certification for Client Protection by M-CRIL. This marks the third time F88 has received this prestigious honour since 2019, and the second consecutive year it has achieved the highest possible rating. The achievement highlights F88's deep and ongoing commitment to building a transparent, sustainable financial ecosystem that puts customers first. Issued by M-CRIL and developed in collaboration with globally recognised organisations Cerise+SPTF, the Client Protection Certification (CPC) is one of the most comprehensive and demanding assessments in the financial services sector. It evaluates how well institutions uphold international standards in client protection, requiring excellence in areas ranging from product design and customer communication to data security and corporate governance. F88's Compliance with M-CRIL Principles To achieve Gold Certification, financial institutions must comply with eight standards, 26 essential practices and over 128 indicators, meeting a minimum compliance rate of 95 per cent and avoiding any disqualifying breaches. F88 surpassed these benchmarks with an impressive 98.3 per cent compliance score, demonstrating the strength of its internal systems and customer-first strategy. This success is not accidental. It stems from a clearly defined and responsibly executed development strategy focused on customer needs and protection. By creating tailored financial solutions to ensure better access to capital and standardising all product information with transparent, easy-to-understand language, F88 has embedded customer care into every step of its operations. The company also commits to a responsible pricing policy, ensuring interest rates and fees are fairly determined and reflective of the services provided. Data protection remains a top priority at F88. Customer data is collected only with explicit consent, securely stored and managed under strict internal controls. This information is then used to fairly assess creditworthiness, helping minimise financial risk for both parties while avoiding over-indebtedness for the customer. Throughout its operations, F88 consistently upholds fairness and integrity. Customers from all backgrounds, including vulnerable groups, receive equal access to financial services. The company adheres to a core principle of 'do no harm', ensuring that all decisions — from product offerings to debt restructuring — are made with the customer's best interest in mind. F88 has also developed a robust, multi-channel feedback and complaint resolution mechanism that allows customers to express concerns easily and expect swift resolution. The company currently resolves over 99 per cent of complaints within 30 days, a figure that reflects not only operational efficiency, but also a strong culture of listening and learning. Underpinning all of this is F88's solid governance structure. With clear internal policies, a strong credit risk management framework and ongoing ethics training for its staff, the company ensures that its team consistently delivers responsible and professional service. Real impact: Earning customer trust and loyalty The impact of these efforts is evident in F88's performance. In the first half of 2025, the company reported a Net Promoter Score of 73 per cent, with over half of its customers returning for additional services — clear signs of growing trust and customer satisfaction. Commenting on the milestone, Chairman and CEO of F88 Phùng Anh Tuấn said: 'A company like F88 cannot grow sustainably by abandoning its social mission in pursuit of short-term profit. Our goal is to grow along with our customers, not to trap them in debt.' Reinforcing market position and investor confidence This recognition comes at a pivotal time for F88. Having recently become a public company and progressing toward listing on the UpCOM exchange, the Gold Certification strengthens its position in the eyes of investors and partners. For stakeholders who value Environmental, Social and Governance (ESG) criteria, it sends a powerful message: F88 is a transparent, ethical and socially responsible business — an organisation that balances profitability with purpose and offers a sound investment opportunity. M-CRIL is a global leader in rating financial institutions and works with investment support from the Asian Development Bank. Through its work, M-CRIL reduces risks for financial entities while encouraging micro and small businesses to adopt best practices.
Free Malaysia Today
3 days ago
- Free Malaysia Today
Mum loses final appeal for defaming ‘Datuk' sons in FB video
The Court of Appeal ruled that the appellant's defence of justification and fair comment was not applicable. PUTRAJAYA : A mother who defamed her two businessmen sons, both of whom have 'Datuk' titles, has lost in her final appeal to set aside the finding of liability and payment of RM200,000 in damages. A three-member Court of Appeal bench chaired by Justice Azimah Omar said the High Court did not err in upholding a sessions court ruling that VT Menaka had lowered the reputation of her sons, M Natarajen and M Satishkumar, through a video posted on Facebook. 'There is no appealable error that warrants appellate intervention. Unfortunately, the sons had to take their mother to court,' she said, adding that the plaintiffs had proved all the elements of libel. Azimah said the 30-minute video in Tamil with a derogatory caption had tarnished the reputation of Menaka's sons. 'The appellant's defence of justification and fair comment is also not applicable,' said the judge, who heard the appeal with Justices Wong Kian Kheong and Ismail Brahim. The bench also ordered Menaka, 67, to pay RM20,000 in costs to her sons. However, lawyer M Manoharan, representing Natarajen,42, and Satishkumar, 41 said Menaka was classified as bankrupt after she had failed to pay the judgment sum and costs of RM10,750 as ordered by the Seremban sessions court in 2023. The mother was ordered to pay RM100,000 in damages each to the sons. 'She filed this appeal after obtaining consent from the insolvency department,' he said. In the posting made on Sept 19, 2020, Menaka claimed that her sons were 'big time' criminals, had forged her signature to remove her as a director of their family company, Linsun Group of Companies Malaysia, and wanted to kill her with a pistol. Lawyer Asmawi Ismail appeared for Menaka.
New Straits Times
4 days ago
- New Straits Times
YSP to ramp up expansion plans, production
KUALA LUMPUR: YSP Southeast Asia Holding Bhd (YSP SAH), one of the top pharmaceutical manufacturers on the FBM KLCI by market capitalisation, is accelerating efforts to grow its presence in both domestic and international markets. Leveraging a combination of offline and online business strategies, the group aims to strengthen its presence in the increasingly competitive pharmaceutical sector. Rashica Lim Yin, head of business development strategy office, e-commerce and consumer healthcare at YSP Industries (M) Sdn Bhd, said the group is committed to growth, underpinned by a strong pipeline of new products and a sustained focus on research and development (R&D). "It's a potential business segment, but also very competitive. That's why we can't rest on our laurels. We must keep innovating and developing products that support the health and wellness of the community," Lim said at the unveiling of the company's latest innovation – the botanical beauty and wellness rituals series by GREENS – during the Greenstopia event in Kuala Lumpur last week. YSP SAH is among the top five pharmaceutical manufacturers in Malaysia. Its operations cover the R&D, manufacturing, warehousing and logistics, and trading of pharmaceutical products ranging from prescription medications and OTC (over-the-counter) remedies to consumer healthcare products, including traditional and complementary medicines. As part of its growth strategy, the company is sharpening its focus on exports, particularly within Asean markets, where demand for affordable quality healthcare products continues to rise in line with expanding private healthcare expenditure across the region. Asked whether current global economic headwinds have impacted operations, Lim said it remains "business as usual" for the company, supported by steady demand for affordable medicines and ongoing product innovation. YSP SAH continues to channel significant investment into R&D to fuel its product pipeline. The group's latest launch – the botanical beauty and wellness rituals series – is an example of this commitment. Lim noted that development for this latest innovation took three years, with its key raw materials sourced from Japan and South Korea. "We are very bullish about the potential of this product and the e-commerce exclusive GREENS series. Patented and clinically proven ingredients supported the product development that we use. We also did extensive market studies to validate demand and growth prospects," she added. Greenstopia, now running in its third year, combines community recycling initiatives with health education and wellness activities. Each Greenstopia edition, including the latest Greenstopia 3.0, encourages attendees to exchange recyclable items such as plastic, aluminium, paper, e-waste and clothing for fresh produce and refreshments, fostering both environmental awareness and community bonding, in line with the GREENS branding vision of creating products that are as close to nature and eco-friendly as possible and with sustainable sources. With a clear strategy to expand its domestic and export markets and a renewed push in health and wellness innovation, YSP SAH is positioning itself to capture new opportunities in an evolving healthcare landscape while reinforcing its standing as one of Malaysia's top pharmaceutical players.
